2015 American Transplant Congress
Outcomes Between ABO-Incompatible Living Donor Liver Transplantation (LDLT) and ABO-Compatible LDLT: A Matched Study
Backgrounds: Reports from several experienced centers suggested that outcomes of an ABO-incompatible (ABOi) living donor liver transplantation (LDLT) after rituximab and reduction of ABO antibodies…2015 American Transplant Congress
Outcomes in Kidney Transplant Recipients Over Age of 55 by Donor Source: LD, SCD, ECD
University of Minnesota, Mpls.
Background: Outcomes in older kidney transplant recipients from SCD and ECD have been studied; however, comparative outcomes between older recipients of LD, SCD and ECD…2015 American Transplant Congress
Social Support After Heart Transplant
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: Social support of patients awaiting heart transplant is mandatory to secure acceptable outcomes after heart transplantation. The types of social support that we have…2015 American Transplant Congress
Pre-Existing Coronary Artery Disease in Lung Transplantat Recipients: Does It Impact Outcomes?
INTRODUCTION:In patients undergoing lung transplantation (LTx), the impact of pre-existing coronary artery disease (CAD) on long-term outcomes is not well understood. This study examines the…2015 American Transplant Congress
Kidney Transplant Outcomes in Marijuana Users
Introduction: As Marijuana use is gaining social acceptance, many transplant centers face questions regarding candidacy of users for kidney transplantation. Currently its impact on post-transplantation…2015 American Transplant Congress
Vitamin D Deficiency in Liver Transplant Recipients: Prevalence, Risk Factors, and Outcomes
Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Vitamin D is known to be immunomodulatory, and its deficiency is associated with multiple chronic health problems in the general population. The objective of this…2015 American Transplant Congress
Outcomes of Post-Kidney Transplant Leukemias
Medicine, University of Minnesota, Minneapolis, MN.
Background:Leukemias typically portend bad prognosis in the general population. The incidence and outcomes of post-kidney transplant leukemias (PKTL) have not been well studied as most…2015 American Transplant Congress
Effects of Anti-Human Leukocyte Antigen Antibody After Heart Transplantation
Cedars-Sinai Heart Institute, Los Angeles, CA.
Purpose: The development of donor-specific antibodies (DSA) after heart transplant has been correlated to the subsequent development of graft rejection. The development of DSA are…
American Transplant Congress abstracts